166P Combination of 5-fluorouracil (FU), interferon (IFN)-alpha2, and nivolumab in unresectable fibrolamellar liver cancer. (December 2022) - Lee, S.; Duan, F.; Jindal, S.; Basu, S.; Yadav, S.; Allison, J.; Sharma, P.; Mohamed, Y.; Kaseb, A.